Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

35.37USD
17 Oct 2014
Price Change (% chg)

$0.30 (+0.86%)
Prev Close
$35.07
Open
$35.40
Day's High
$35.60
Day's Low
$34.95
Volume
833,458
Avg. Vol
751,136
52-wk High
$37.97
52-wk Low
$28.14

ZTS.N

Chart for ZTS.N

About

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs,... (more)

Overall

Beta: --
Market Cap (Mil.): $17,727.21
Shares Outstanding (Mil.): 501.19
Dividend: 0.07
Yield (%): 0.81

Financials

  ZTS.N Industry Sector
P/E (TTM): 33.61 32.64 33.19
EPS (TTM): 1.05 -- --
ROI: 10.22 18.40 17.65
ROE: 51.17 19.06 18.46
Search Stocks

Zoetis granted conditional license by USDA for PEDv vaccine

CHICAGO - Zoetis Inc has received a conditional license from the U.S. Department of Agriculture for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.

03 Sep 2014

UPDATE 1-Zoetis granted conditional license by USDA for PEDv vaccine

* Stock price hits record high (Adds USDA comment, stock price)

03 Sep 2014

Zoetis granted conditional license by USDA for PEDv vaccine

CHICAGO, Sept 3 - Zoetis Inc, the world's largest animal-health company, has received a conditional license from the U.S. Agriculture Department for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.

03 Sep 2014

Zoetis plans vaccine against killer U.S. pig virus

CHICAGO - Zoetis Inc, the world's largest animal-health company, plans to seek U.S. approval before the end of this year to sell its vaccine against a virus that has killed about 13 percent of the U.S. hog herd.

05 Aug 2014

Zoetis plans vaccine against killer U.S. pig virus

CHICAGO, Aug 5 - Zoetis Inc, the world's largest animal-health company, plans to seek U.S. approval before the end of this year to sell its vaccine against a virus that has killed about 13 percent of the U.S. hog herd.

05 Aug 2014

Novartis, Valeant bids herald new deal-making era for pharma

- A series of agreed or proposed drug company deals may herald a new era of acquisitions not seen since last decade as pharmaceutical companies improve their best businesses and exit weaker ones.

23 Apr 2014

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF81.65 -0.55
Merck & Co., Inc. (MRK.N) $54.02 +0.59
Bayer AG (BAYGn.DE) €102.30 -2.55
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €79.75 -1.50
Eli Lilly and Co (LLY.N) $62.58 +0.68

Earnings vs. Estimates

Search Stocks